TELA Bio, Inc. Operating Expenses
TELA Bio, Inc. (TELA) reported Operating Expenses of $23.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-11
- TELA Bio, Inc. operating expenses for the quarter ending 2026-06-30 was $23.23M, a 0.17% increase year-over-year.
- TELA Bio, Inc. operating expenses for the quarter ending 2026-03-31 was $23.05M, a 0.27% increase year-over-year.
- TELA Bio, Inc. operating expenses for the quarter ending 2025-12-31 was $20.40M, a 4.23% increase year-over-year.
- TELA Bio, Inc. operating expenses for the quarter ending 2025-09-30 was $21.52M, a 3.15% decline year-over-year.
- TELA Bio, Inc. operating expenses for fiscal 2025 was $88.10M, a 0.10% decline from fiscal 2024.
- TELA Bio, Inc. operating expenses for fiscal 2024 was $88.18M, a 4.75% increase from fiscal 2023.
- TELA Bio, Inc. operating expenses for fiscal 2023 was $84.19M, a 27.46% increase from fiscal 2022.
- TELA Bio, Inc. operating expenses for fiscal 2022 was $66.05M, a 36.85% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.23M 10-Q · filed 2026-08-11 | $46.27M 10-Q · filed 2026-08-11 | $66.67M derived: sum of 3 quarters · filed 2026-08-11 | $88.20M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $23.05M 10-Q · filed 2026-05-13 | $43.45M derived: sum of 2 quarters · filed 2026-05-13 | $64.97M derived: sum of 3 quarters · filed 2026-05-13 | $88.16M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $20.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $41.93M derived: sum of 2 quarters · filed 2026-03-25 | $65.11M derived: sum of 3 quarters · filed 2026-08-11 | $88.10M 10-K · filed 2026-03-25 |
| 2025-09-30 | $21.52M 10-Q · filed 2025-11-14 | $44.71M derived: sum of 2 quarters · filed 2026-08-11 | $67.69M 10-Q · filed 2025-11-14 | $87.27M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $23.19M 10-Q · filed 2026-08-11 | $46.17M 10-Q · filed 2026-08-11 | $65.75M derived: sum of 3 quarters · filed 2026-08-11 | $87.97M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $22.98M 10-Q · filed 2026-05-13 | $42.56M derived: sum of 2 quarters · filed 2026-05-13 | $64.78M derived: sum of 3 quarters · filed 2026-05-13 | $87.42M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $19.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $41.80M derived: sum of 2 quarters · filed 2026-03-25 | $64.44M derived: sum of 3 quarters · filed 2026-03-25 | $88.18M 10-K · filed 2026-03-25 |
| 2024-09-30 | $22.22M 10-Q · filed 2025-11-14 | $44.87M derived: sum of 2 quarters · filed 2025-11-14 | $68.61M 10-Q · filed 2025-11-14 | $92.51M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $22.64M 10-Q · filed 2025-08-11 | $46.38M 10-Q · filed 2025-08-11 | $70.29M derived: sum of 3 quarters · filed 2026-03-25 | $90.86M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $23.74M 10-Q · filed 2025-05-08 | $47.64M derived: sum of 2 quarters · filed 2026-03-25 | $68.21M derived: sum of 3 quarters · filed 2026-03-25 | $88.78M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $44.47M derived: sum of 2 quarters · filed 2026-03-25 | $65.03M derived: sum of 3 quarters · filed 2026-03-25 | $84.19M 10-K · filed 2026-03-25 |
| 2023-09-30 | $20.57M 10-Q · filed 2024-11-08 | $41.13M derived: sum of 2 quarters · filed 2024-11-08 | $60.28M 10-Q · filed 2024-11-08 | $77.90M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $20.56M 10-Q · filed 2024-08-13 | $39.72M 10-Q · filed 2024-08-13 | $57.33M derived: sum of 3 quarters · filed 2025-03-21 | $74.14M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | $19.15M 10-Q · filed 2024-05-10 | $36.77M derived: sum of 2 quarters · filed 2025-03-21 | $53.57M derived: sum of 3 quarters · filed 2025-03-21 | $70.36M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | $17.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $34.42M derived: sum of 2 quarters · filed 2025-03-21 | $51.21M derived: sum of 3 quarters · filed 2025-03-21 | $66.05M 10-K · filed 2025-03-21 |
| 2022-09-30 | $16.81M 10-Q · filed 2023-11-13 | $33.59M derived: sum of 2 quarters · filed 2023-11-13 | $48.44M 10-Q · filed 2023-11-13 | $61.75M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $16.79M 10-Q · filed 2023-08-10 | $31.63M 10-Q · filed 2023-08-10 | $44.94M derived: sum of 3 quarters · filed 2024-03-22 | $56.76M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $14.84M 10-Q · filed 2023-05-11 | $28.16M derived: sum of 2 quarters · filed 2024-03-22 | $39.98M derived: sum of 3 quarters · filed 2024-03-22 | $52.37M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $25.13M derived: sum of 2 quarters · filed 2024-03-22 | $37.53M derived: sum of 3 quarters · filed 2024-03-22 | $48.26M 10-K · filed 2024-03-22 |
| 2021-09-30 | $11.82M 10-Q · filed 2022-11-10 | $24.22M derived: sum of 2 quarters · filed 2022-11-10 | $34.95M 10-Q · filed 2022-11-10 | $45.36M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $12.40M 10-Q · filed 2022-08-11 | $23.13M 10-Q · filed 2022-08-11 | $33.54M derived: sum of 3 quarters · filed 2023-03-23 | $43.69M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $10.73M 10-Q · filed 2022-05-11 | $21.14M derived: sum of 2 quarters · filed 2023-03-23 | $31.29M derived: sum of 3 quarters · filed 2023-03-23 | $38.54M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $20.56M derived: sum of 2 quarters · filed 2023-03-23 | $27.81M derived: sum of 3 quarters · filed 2023-03-23 | $36.51M 10-K · filed 2023-03-23 |
| 2020-09-30 | $10.15M 10-Q · filed 2021-11-12 | $17.40M derived: sum of 2 quarters · filed 2021-11-12 | $26.10M 10-Q · filed 2021-11-12 | $34.89M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $7.25M 10-Q · filed 2021-08-12 | $15.95M 10-Q · filed 2021-08-12 | $24.74M derived: sum of 3 quarters · filed 2022-03-23 | $31.20M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $8.70M 10-Q · filed 2021-05-14 | $17.49M derived: sum of 2 quarters · filed 2022-03-23 | $23.95M derived: sum of 3 quarters · filed 2022-03-23 | $30.16M derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $15.25M derived: sum of 2 quarters · filed 2022-03-23 | $21.46M derived: sum of 3 quarters · filed 2022-03-23 | $28.43M 10-K · filed 2022-03-23 |
| 2019-09-30 | $6.46M 10-Q · filed 2020-11-12 | $12.67M derived: sum of 2 quarters · filed 2020-11-12 | $19.64M 10-Q · filed 2020-11-12 | $26.17M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $6.21M 10-Q · filed 2020-08-13 | $13.19M 10-Q · filed 2020-08-13 | $19.71M derived: sum of 3 quarters · filed 2021-03-25 | $23.60M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $6.98M 10-Q · filed 2020-05-15 | $13.50M derived: sum of 2 quarters · filed 2021-03-25 | $17.39M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $10.42M derived: sum of 2 quarters · filed 2021-03-25 | $20.72M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $3.89M 10-Q · filed 2019-12-18 | $14.20M 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | $19.46M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |